These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 3019376)
41. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma. Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896 [TBL] [Abstract][Full Text] [Related]
42. Characterization of a newly established human Burkitt's lymphoma cell line, OMA-BL-1. Joshi SS; DeBoer JM; Strandjord SJ; Pirruccello SJ; Sanger WG; Weisenburger DD; Sharp JG Int J Cancer; 1991 Mar; 47(5):643-8. PubMed ID: 1848532 [TBL] [Abstract][Full Text] [Related]
43. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases]. Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633 [TBL] [Abstract][Full Text] [Related]
44. Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA. Minarovits J; Minarovits-Kormuta S; Ehlin-Henriksson B; Falk K; Klein G; Ernberg I J Gen Virol; 1991 Jul; 72 ( Pt 7)():1591-9. PubMed ID: 1649897 [TBL] [Abstract][Full Text] [Related]
45. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1). Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297 [TBL] [Abstract][Full Text] [Related]
46. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5. Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080 [TBL] [Abstract][Full Text] [Related]
48. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Schaefer BC; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841 [TBL] [Abstract][Full Text] [Related]
49. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649 [TBL] [Abstract][Full Text] [Related]
50. Japanese Burkitt's lymphoma: clinicopathological review of 14 cases. Miyoshi I Jpn J Clin Oncol; 1983 Sep; 13(3):489-96. PubMed ID: 6315992 [TBL] [Abstract][Full Text] [Related]
51. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. Gregory CD; Murray RJ; Edwards CF; Rickinson AB J Exp Med; 1988 Jun; 167(6):1811-24. PubMed ID: 2898508 [TBL] [Abstract][Full Text] [Related]
52. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Sample J; Brooks L; Sample C; Young L; Rowe M; Gregory C; Rickinson A; Kieff E Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6343-7. PubMed ID: 1648738 [TBL] [Abstract][Full Text] [Related]
53. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047 [TBL] [Abstract][Full Text] [Related]
54. Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin. Favrot MC; Philip I; Philip T; Portoukalian J; Doré JF; Lenoir GM J Natl Cancer Inst; 1984 Oct; 73(4):841-7. PubMed ID: 6592381 [TBL] [Abstract][Full Text] [Related]
55. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression. Wolf J; Pawlita M; Bullerdiek J; zur Hausen H Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373 [TBL] [Abstract][Full Text] [Related]
56. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003 [TBL] [Abstract][Full Text] [Related]
57. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Klein G; Lindahl T; Jondal M; Leibold W; Menézes J; Nilsson K; Sundström C Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3283-6. PubMed ID: 4369887 [TBL] [Abstract][Full Text] [Related]
58. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341 [TBL] [Abstract][Full Text] [Related]
60. Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma. Trivedi P; Zhang QJ; Chen F; Minarovits J; Ekman M; Biberfeld P; Klein G; Winberg G Oncogene; 1995 Aug; 11(3):505-10. PubMed ID: 7630634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]